Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Revenue (2019 - 2025)

Cyclerion Therapeutics (CYCN) has 6 years of Revenue data on record, last reported at $875000.0 in Q3 2025.

  • For Q3 2025, Revenue rose 351.03% year-over-year to $875000.0; the TTM value through Sep 2025 reached $2.9 million, up 1371.65%, while the annual FY2024 figure was $2.0 million, N/A changed from the prior year.
  • Revenue reached $875000.0 in Q3 2025 per CYCN's latest filing, up from $93000.0 in the prior quarter.
  • Across five years, Revenue topped out at $3.0 million in Q2 2021 and bottomed at -$720000.0 in Q3 2022.
  • Average Revenue over 4 years is $607333.3, with a median of $326500.0 recorded in 2021.
  • The widest YoY moves for Revenue: up 1046.77% in 2022, down 307.49% in 2022.
  • A 4-year view of Revenue shows it stood at $533000.0 in 2021, then crashed by 235.08% to -$720000.0 in 2022, then soared by 350.83% to $1.8 million in 2024, then tumbled by 51.55% to $875000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $875000.0 in Q3 2025, $93000.0 in Q2 2025, and $81000.0 in Q1 2025.